SHELDON KRIMSKY
Professor of Urban & Environmental Policy & Planning

 

Selected Publications in Science & Ethics

Please note: articles that are available in PDF format are marked with a PDF icon.

20. Commentary on the retraction of scientific articles. Nature Genetics 30:139(February 2002).

19. Journal Policies on Conflict of Interest: If this is the Therapy, What's the Disease [Editorial]. Psychotherapy and Psychosomatics 70:115-117(2001).

18. Conflict of Interest Policies in Science and Medical Journals: Editorial Practices and Author Disclosures. (with L.S. Rothenberg). Science and Engineering Ethics 7:205-218(April 2001).

17. Scientific journals and their authors' financial interests (reprinted). In: The Commercialization of Genetics Research. T.A. Caulfield and B. William-Jones, ed. New York: Klewer Academic Publishers, 2000.

16. Commentary on "Politics of Certainty." Science and Engineering Ethics 6(4):509-510 (2000).

15. The Psychosocial Limits on Human Germline Modification. In: Engineering the Human Germline. G. Stock and J. Campbell, eds. Oxford, 2000.

14. Conflicts of Interest and Cost-effectiveness Analysis [Editorial] JAMA 282:1474-6 (October 20, 1999).

13. The Profit of Scientific Discovery and its Normative Implications. Chicago Kent Law Review. 75(1):15-39(1999).

12. Review: Research Misconduct: Issues, Implications and Strategies, E. Altman and P. Hernon, eds. NEJM 339(8):568(August 20, 1998).

11. Scientific Journals and Their Authors' Financial Interests: A Pilot Study (w. L.S Rothenberg, P. Stott, and G. Kyle). Psychotherapy and Psychosomatics 67(4-5):194-201(1998). Reprinted in: The Commercialization of Genetic Research T.A. Caulfield and B. Williams-Jones, eds. New York: Kluwer, 1999.

10. Financial Interest of Authors in Scientific Journals: A Pilot Study of 14 Publications (with Rothenberg, Stott and Kyle). Science and Engineering Ethics 2(4):395-410(1996).

9. Commentary: "The Hazards of Whistleblowers and on Some Problems of Young Biomedical Scientists in our Time" by John Edsall. Science and Engineering Ethics 1(4):341-344(1995).

8. Science, Money and Innovation. [Review]. Profits of Science by Robert Teitelman. Forum for Applied Research and Public Policy. 10(4):146-7(Winter1995).

7. The Business of Research. (w. Ruth Hubbard) Hastings Center Report25(1):41-43 (Jan/Feb 1995).

6. Science, Society, and the Expanding Boundaries of Moral Discourse. Science, Politics and Social Practice. Boston Studies in the Philosophy of Science. Dordrecht:Kluwer, 1995.

5. Review: Democratic Values and Technological Choices. Stuart Hill. Stanford Univ. Press, 1992. In American Scientist 82:90-91(January-February 1994).

4. Human Gene Therapy: Must We Know Where to Stop Before We Begin. Human Gene Therapy 1(2)71-173 (1990).

3. University Entrepreneurship and Public Purpose. Biotechnology: Professional Issues and Social Concerns. Washington DC: American Association for the Advancement of Science. October 1988.

2. Review:Biotechnology: The University-Industry Complex by Martin Kenney. New Haven: Yale University Press, 1987. In American ScientistSept-Oct. 1987, p. 549.

1. The New Corporate Identity of the American University. Alternatives. 14(2):20-29 (May/June 1987).

 

 


Bio | Publications | Science & Ethics Publications | Biotechnology Publications | Endocrine Disruptors Publications | Risk Analysis Publications | Books | Commentaries | Book Reviews | Courses | Links | Corrupted Science | Home 


©2005 Sheldon Krimsky